The company has operationalized diagnostics center at Ferozepur, Gurdaspur, Nawanshahr, and Kapurthala in Punjab.
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
The tenure of contract will be upto 10 years from date of signing the contract/installation.
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Krsnaa Diagnostics now has its footprints in Delhi.
To address the preventive & primary healthcare delivery gaps in India
Subscribe To Our Newsletter & Stay Updated
